Study: Low doses of cancer drug stimulate tumor growth

03/23/2009 | BBC

A study on mice found that the anti-angiogenesis drug cilengitide, which is designed to impede the growth of tumor blood vessels, stimulated the development of cancers when given at low doses. The research could help improve the effectiveness of cancer treatments such as Avastin and Sutent, cancer experts said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX